Abstract
Flexible intensive insulin therapy (FIIT) has demonstrated favorable results on quality of life and glycemic control for people with type 1 diabetes mellitus. People with type 2 diabetes mellitus using basal-bolus insulin may also benefit from FIIT, but little research exists on use of FIIT in this population. This pilot study explored the experiences of persons with type 2 diabetes who were new users of FIIT. Study outcomes suggest FIIT is safe and effective in this population. Dietitians are well-positioned to help select appropriate candidates for this diabetes self-management approach. In addition, dietitians can contribute to success rates with counseling and carbohydrate education.